2021 Scientific Sessions

Reduction of Recurrent Strokes in Patients with PFO: Long-Term Outcomes

Sponsored by: W.L. Gore

The 5-year REDUCE study evaluated the GORE® CARDIOFORM Septal Occluder for treatment of PFO in the stetting of cryptogenic stroke. In this session Matthew J. Price, M.D. and Robert J. Sommer, M.D. will review the recently published REDUCE long-term data and discuss how the results can influence patent foramen ovale (PFO) treatment going forward.

Background Discussion on PFO and Stroke Prevention; REDUCE Results (Median of 3.2 Years); REDUCE Results (Median of 5 Years); PFO Closure Patient Selection and Treatment Practices
Matthew J. Price, MD, Scripps Clinic Medical Group, La Jolla, CA and Robert J. Sommer, M.D., NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY
View Recording
See more of: Structural Heart Disease
<< Previous Session | Next Session >>